This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Coster, T. S. Articles by McQueen, C. E. Search for Related Content PubMed PubMed Citation Articles by Coster, T. S. Articles by McQueen, C. E.

 Previous Article  |  Next Article 

Infection and Immunity, January 2007, p. 252-259, Vol. 75, No. 1
0019-9567/07/$08.00+0     doi:10.1128/IAI.01131-06

Immune Response, Ciprofloxacin Activity, and Gender Differences after Human Experimental Challenge by Two Strains of Enterotoxigenic Escherichia coli

T. S. Coster,¹ M. K. Wolf,^2* E. R. Hall,^3, F. J. Cassels,² D. N. Taylor,^2, C. T. Liu,¹ F. C. Trespalacios,^1,¶ A. DeLorimier,^2, D. R. Angleberger,¹ and C. E. McQueen^2,

U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland 21702,¹ Walter Reed Army Institute of Research, Silver Spring, Maryland 20910,² Naval Medical Research Center, Walter Reed Forest Glen Annex, Silver Spring, Maryland 20910³

Received 19 July 2006/ Returned for modification 21 August 2006/ Accepted 13 October 2006

In order to test vaccines against enterotoxigenic Escherichia coli (ETEC)-induced diarrhea, challenge models are needed. In this study we compared clinical and immunological responses after North American volunteers were orally challenged by two ETEC strains. Groups of approximately eight volunteers received 10⁹ or 10¹⁰ CFU of E. coli B7A (LT⁺ ST⁺ CS6⁺) or 10⁸ or 10⁹ CFU of E. coli H10407 (LT⁺ ST⁺ CFA/I⁺). About 75% of the volunteers developed diarrhea after challenge with 10¹⁰ CFU B7A or either dose of H10407. B7A had a shorter incubation period than H10407 (P = 0.001) and caused milder illness; the mean diarrheal output after H10407 challenge was nearly twice that after B7A challenge (P = 0.01). Females had more abdominal complaints, and males had a higher incidence of fever. Ciprofloxacin generally diminished or stopped symptoms and shedding by the second day of antibiotic treatment, but four subjects shed for one to four additional days. The immune responses to colonization factors CS6 and colonization factor antigen I (CFA/I) and to heat-labile toxin (LT) were measured. The responses to CFA/I were the most robust responses; all volunteers who received H10407 had serum immunoglobulin A (IgA) and IgG responses, and all but one volunteer had antibody-secreting cell (ASC) responses. One-half the volunteers who received B7A had an ASC response to CS6, and about one-third had serum IgA or IgG responses. Despite the differences in clinical illness and immune responses to colonization factors, the immune responses to LT were similar in all groups and were intermediate between the CFA/I and CS6 responses. These results provide standards for immune responses after ETEC vaccination.

---

* Corresponding author. Mailing address: Division of Regulated Activities, Walter Reed Army Institute of Research, Silver Spring, MD 20910-7500. Phone: (301) 319-9978. Fax: (301) 319-9585. E-mail: Marcia.Wolf{at}amedd.army.mil.

Published ahead of print on 30 October 2006.

Editor: W. A. Petri, Jr.

Present address: Naval Medical Research Center Detachment Unit 3800, APO AA 34031-3800.

Present address: Salix Pharmaceuticals, 8540 Colonnade Center Drive, Raleigh, NC 27615.

^¶ Present address: 9210 SW 75^th St., Miami, FL 33173.

Present address: Walter Reed Army Medical Center, 6900 Georgia Ave., NW, Washington, DC 20307-5001.

---

Infection and Immunity, January 2007, p. 252-259, Vol. 75, No. 1
0019-9567/07/$08.00+0     doi:10.1128/IAI.01131-06

This article has been cited by other articles:

• Porter, C. K., El Mohammady, H., Baqar, S., Rockabrand, D. M., Putnam, S. D., Tribble, D. R., Riddle, M. S., Frenck, R. W., Rozmajzl, P., Kilbane, E., Fox, A., Ruck, R., Lim, M., Johnston, Y. J., Murphy, E., Sanders, J. W. (2008). Case Series Study of Traveler's Diarrhea in U.S. Military Personnel at Incirlik Air Base, Turkey. CVI 15: 1884-1887 [Abstract] [Full Text]  
• Lapa, J. A., Sincock, S. A., Ananthakrishnan, M., Porter, C. K., Cassels, F. J., Brinkley, C., Hall, E. R., van Hamont, J., Gramling, J. D., Carpenter, C. M., Baqar, S., Tribble, D. R. (2008). Randomized Clinical Trial Assessing the Safety and Immunogenicity of Oral Microencapsulated Enterotoxigenic Escherichia coli Surface Antigen 6 with or without Heat-Labile Enterotoxin with Mutation R192G. CVI 15: 1222-1228 [Abstract] [Full Text]  
• Roy, K., Hamilton, D., Allen, K. P., Randolph, M. P., Fleckenstein, J. M. (2008). The EtpA Exoprotein of Enterotoxigenic Escherichia coli Promotes Intestinal Colonization and Is a Protective Antigen in an Experimental Model of Murine Infection. Infect. Immun. 76: 2106-2112 [Abstract] [Full Text]  
• Lasaro, M. A., Rodrigues, J. F., Mathias-Santos, C., Guth, B. E. C., Balan, A., Sbrogio-Almeida, M. E., Ferreira, L. C. S. (2008). Genetic Diversity of Heat-Labile Toxin Expressed by Enterotoxigenic Escherichia coli Strains Isolated from Humans. J. Bacteriol. 190: 2400-2410 [Abstract] [Full Text]